Scores for Predicting Aminoglycosides Nephrotoxicity - Equations

Evaluation

Are you evaluating a patient being treated with aminoglycosides for risk of nephrotoxicity?

Yes

Age

years

Gender of the patient

Male

Female

Does the patient have liver disease?

Yes

Is the patient in shock?

Yes

Initial creatinine clearance

mL/min

Initial 1 hour peak post-dose level

µg/mL

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Discriminant function with data available before therapy

Discriminant function with data available by 72 hours

Probability of developing nephrotoxicity based on the 72 hour data

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Risk Factors for Atazanavir Urolithiasis in HIV-Positive Patient
- Congestive Heart Failure | Risk Factors for Acute Renal Insufficiency Associated with Diuretic Therapy
Clinical Diagnosis, Including Family History For Genetics
- Clinical Features of Indinavir Nephropathy

Therapy

Selection
- Risk Factors for Atazanavir Urolithiasis in HIV-Positive Patient
- Congestive Heart Failure | Risk Factors for Acute Renal Insufficiency Associated with Diuretic Therapy

Monitoring

Adverse Effects
- Fanconi Syndrome Associated with Tenofovir Therapy in HIV-Positive Patient

Specialty

Nephrology
Clinical Laboratory
Pharmacology, clinical

Objective

risk factors

ICD-10

Y40.5 - Adverse effects in therapeutic use, aminoglycosides

Discriminant Scores for Predicting Aminoglycoside Nephrotoxicity

Purpose: To predict nephrotoxicity in a patient treated with aminoglycosides using the discriminant equations of Moore et al.